Brief: Sprint Bioscience Q2 Net Sales Up At SEK 16.7 Mln
Aug 28 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* Q2 NET SALES DURING THE QUARTER AMOUNTED TO SEK 16.7 (0)
MILLION
* Q2 OPERATING RESULT FOR THE QUARTER AMOUNTED TO SEK -5.6
(-11.8)
MILLION
Source text for Eikon: ID:nMFN7fKSCp
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience And Max IV Receive Funding From Vinnova
Brief: Sprint Bioscience Q2 Loss After Tax SEK 16.2 Million
Brief: Sprint Bioscience Announces Deal With Lilly Tunelab
Brief: Sprint Bioscience Partners With Lilly Tunelab For Drug Development
Brief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln